Innovative Cancer Detection Avenda Health's flagship product, Unfold AI, utilizes advanced AI technology to reveal hidden forms of cancer, offering a significant value proposition for hospitals and clinics seeking to improve diagnostic accuracy and patient outcomes in oncology care.

Recognition and Awards The company has recently received top awards and recognition within the digital health sector, including the Digital Health Award at HLTH, highlighting its leadership in AI-driven healthcare solutions, which can strengthen its credibility and appeal to potential partners.

Expanding Clinical Evidence Avenda has presented new clinical data at major urological meetings and launched studies at UCLA, demonstrating the effectiveness of its AI in tumor margin detection and treatment prediction — opportunities to engage hospitals and research institutions for large-scale implementation.

Recent Funding Growth With a recent $3.5 million venture capital raise, the company shows promising financial momentum, making it a compelling candidate for strategic partnerships, pilot programs, or additional investment to scale its AI platform.

Strategic Industry Presence The company's innovations in robotic HIFU procedures and personalized prostate cancer therapy position it as a leader in the intersection of AI, robotics, and oncology, creating opportunities to collaborate with healthcare providers looking to adopt cutting-edge cancer treatments.